OVERVIEW
The global custom antibody market is expected to hit USD 586 million by 2025, rising over the forecast period at a CAGR of 8.12 per cent. The growth of this market is driven mainly by the increase in research activities in the life sciences industry, the growth of partnerships between industry and academia, the expansion of the antibody therapy pipeline, and the increasing quality concerns over catalog antibodies that push end users towards custom antibodies.








TABLE OF CONTENT
1 Global Custom Antibody Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Custom Antibody Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Custom Antibody Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Custom Antibody Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Custom Antibody Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Custom Antibody Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Custom Antibody Market – By Service (Market Size – & million/billion)
8.1 Antibody Development
8.2 Antibody Production & Purification
8.3 Antibody Fragmentation & Labeling
9 Global Custom Antibody Market – By Type
9.1 Monoclonal Antibodies
9.2 Polyclonal Antibodies
9.3 Recombinant Antibodies
10 Global Custom Antibody Market – By Source
10.1 Mice
10.2 Rabbits
10.3 Others
11 Global Custom Antibody Market – By Research Area
11.1 Oncology
11.2 Immunology
11.3 Infectious Diseases
11.4 Neurobiology
11.5 Cardiovascular Diseases
11.6 Stem Cells
11.7 Other
12 Global Custom Antibody Market – By End User
12.1 Pharmaceutical & Biotechnology Companies
12.2 Contract Research Organizations
12.3 Academic & Research Institutes
13 Global Custom Antibody Market – By Geography (Market Size – & million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa
14 Global Custom Antibody Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships
15 Global Custom Antibody Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Thermo Fisher Scientific Inc.
15.3 Agilent Technologies, Inc.
15.4 Genscript
15.5 Rockland Immunochemicals Inc.
15.6 Promab Biotechnologies, Inc.
15.7 Abcam PLC
15.8 Cell Signaling Technology, Inc.
15.9 Merck Group
15.10 Bio-Rad Laboratories, Inc.
15.11 Biolegend, Inc.
15.12 Company 11 & more
16 Global Custom Antibody Market – Appendix
16.1 Sources
16.2 Abbreviations